Does RIFAXIMIN Cause Therapy interrupted? 875 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 875 reports of Therapy interrupted have been filed in association with RIFAXIMIN (XIFAXAN). This represents 6.3% of all adverse event reports for RIFAXIMIN.
875
Reports of Therapy interrupted with RIFAXIMIN
6.3%
of all RIFAXIMIN reports
162
Deaths
563
Hospitalizations
How Dangerous Is Therapy interrupted From RIFAXIMIN?
Of the 875 reports, 162 (18.5%) resulted in death, 563 (64.3%) required hospitalization, and 9 (1.0%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 875 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
Hepatic encephalopathy (462)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which RIFAXIMIN Alternatives Have Lower Therapy interrupted Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB